Amanote Research
Register
Sign In
P1 Omalizumab in Paediatric Asthma: Importance of Multi-Disciplinary Assessment to Identify Eligible Patients
Thorax
- United Kingdom
doi 10.1136/thoraxjnl-2012-202678.142
Full Text
Open PDF
Abstract
Available in
full text
Categories
Pulmonary
Respiratory Medicine
Date
November 19, 2012
Authors
S Rao
L Barrett
S Frost
Publisher
BMJ
Related search
Omalizumab Treatment in Brittle Asthma
Postepy Dermatologii I Alergologii
Dermatology
Allergy
Immunology
Omalizumab in Patients With Severe Asthma and Persistent Sputum Eosinophilia
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Appropriate Selection for Omalizumab Treatment in Patients With Severe Asthma?
European Clinical Respiratory Journal
Effects of Omalizumab on Blood Eosinophil Numbers in Patients With Allergic Asthma
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Therapeutic Switch From Omalizumab to Mepolizumab in Patients With Uncontrolled Severe Eosinophilic Asthma: Treatment Effect by Prior Omalizumab Treatment Duration
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Paediatric Asthma: Where to Go?
European Respiratory Review
Pulmonary
Respiratory Medicine
Prs106 - The Assessment the Quality of Life in Children With Severe Persistent Uncontrolled Asthma, Receiving Omalizumab, by the Health Utilities Index and Standardised Paediatric Asthma Quality of Life Questionnaire(according to the Pediatric Registry)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
PRS44 Cost Utility Analysis of Omalizumab Therapy for Severe Asthma Patients in Thailand
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prs61 - Assessment of Asthma-Diagnosed Population Eligible for New Monoclonal Antibody Therapy in Veneto Region
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
